News and Announcements
Pacsim Makes First Airline Sale
- Published January 17, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- $2 million in sales in last 3 months of 2017
- First simulator sale to an airline
- Certified simulator sold to University of South Australia
- Flight Experience network expands to 19 locations
Pacific Simulators has had a busy end to 2017 with 5 sales, both training and entertainment, since October. A significant development has been the sale of a training simulator to Bolivian Airlines, who run a small fleet of Boeing 737’s. Whilst several airlines have been using Pacsim simulators, Bolivian is the first to purchase one for their own specific needs, and marks an important step in the acceptance of our products for the airline training market.
Two training products have been sold to UniSA in Adelaide and Ardmore Flying School in Auckland, NZ. Both devices will be used to expand the training capabilities for commercial pilots.Pacsim is also in the final stages of closing another Australian-based airline sale and another NZ flight school.
Flight Experience will also expand to a total of 19 outlets by mid 2018 with sales to Amana Entertainment Group in Qatar and a Chinese property company based in Tangshan. Since presenting at the Wholesale Investor November luncheon, Pacsim has attracted interest from a number of parties and is continuing discussions with them for investment. Investment is required to take the next step in airline certification of the Airbus A320 and Boeing 737 simulators.
About Pacific Simulators 2010 Ltd
Pacific Simulators (Pacsim) is a flight simulator manufacturer who have designed and built cost-effective training simulators suitable for airlines.
The airline industry is booming with over 12,000 Boeing and Airbus planes on order and a demand for nearly 700,000 pilots over the next 20 years.
Pacsim have created the perfect simulator solution to enable cost-effective training with better training outcomes for airlines with Boeing 737 and Airbus A320 aircraft.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
